Assignee
MEHTA KETAN
US·9 granted patents·1 pending application·798 citations·filing 2007–2012
Top patents by PatentIndex Score
10 records- 0198US8623409B1Clonidine formulationMEHTA KETAN·Filed 2010·Granted Jan 7, 2014·60 cites·28 claims
- 0298US8465765B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2012·Granted Jun 18, 2013·71 cites·30 claims
- 0398US8337890B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2010·Granted Dec 25, 2012·79 cites·29 claims
- 0498US8287903B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2011·Granted Oct 16, 2012·88 cites·30 claims
- 0598US8202537B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2011·Granted Jun 19, 2012·94 cites·24 claims
- 0698US8062667B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2007·Granted Nov 22, 2011·119 cites·55 claims
- 0796US8512688B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2012·Granted Aug 20, 2013·68 cites·19 claims
- 0896US8287848B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2007·Granted Oct 16, 2012·87 cites·24 claims
- 0996US8202542B1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2008·Granted Jun 19, 2012·132 cites·25 claims
- 1054US2012148672A1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →